Dexamethasone impairs cholesterol egress from a localized lipoprotein depot in vivo

Atherosclerosis

Volumn 137, Issue 2, 1998, Pages 303-310

  Stein, O ^a   Dabach, Y ^b   Hollander, G ^b   Ben Naim, M ^a   Halperin, G ^c   Stein, Y ^b  

^a HEBREW UNIVERSITY   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c Sheba Hospital   (Israel)

Author keywords

Atherosclerosis; Cationized LDL; Cholesterol esterification; Cholesteryl ester hydrolysis; Reverse cholesterol transport

Indexed keywords

CHOLESTEROL; CHOLESTEROL ESTER; DEXAMETHASONE; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL ESTERIFICATION; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DEXAMETHASONE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HYDROLYSIS; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; STEROL O-ACYLTRANSFERASE;

EID: 17544387915     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)00294-3     Document Type: Article

References (32)

1. Stein O., Dabach Y., Hollander G., Ben-Naim M., Halperin G., Okon E., Stein Y. Cholesterol efflux in vivo from a depot of cationized LDL injected into a thigh muscle of small rodents. Atherosclerosis. 133:1997;15-22.
2. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:1993;801-809.
3. Hansson G.K., Jonasson L., Seifert P.S., Stemme S. Immune mechanisms in atherosclerosis. Arteriosclerosis. 9:1989;567-578.
4. Leibovich S.J., Ross R. The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. Am J Pathol. 78:1975;71-100.
5. Hagihara H., Nomoto A., Mutoh S., Yamaguchi I., Ono T. Role of anti-inflammatory responses in initiation of atherosclerosis: Effects of anti-inflammatory drugs on cuff-induced leukocyte accumulation and intimal thickening of rabbit carotid artery. Atherosclerosis. 91:1991;107-116.
6. Bailey J.M., Butler J. Anti-inflammatory drugs in experimental atherosclerosis: 1. Relative potencies for inhibiting plaque formation. Atherosclerosis. 17:1973;515-522.
7. Naito M., Yasue M., Asai K., Yamada K., Hayashi T., Kuzuya M., Funaki C., Yoshimine N., Kuzuya F. Effects of dexamethasone on experimental atherosclerosis in cholesterol-fed rabbits. J Nutr Sci Vitaminol (Tokyo). 38:1992;255-264.
8. Asai K., Funaki C., Hayashi T., Yamada K., Naito M., Masafumi K., Futoshi Y., Noboru Y., Kuzuya F. Dexamethasone-induced suppression of aortic atherosclerosis in cholesterol-fed rabbits. Possible mechanisms. Arterio Thromb. 13:1993;892-899.
9. Makheja A.N., Bloom S., Muesing R., Simon T., Bailey J.M. Anti-inflammatory drugs in experimental atherosclerosis; 7. Spontaneous atherosclerosis in WHHL rabbits and inhibition by cortisone acetate. Atherosclerosis. 76:1989;155-161.
10. Zimmerman J., Fainaru M., Eisenberg S. The effects of prednisone therapy on plasma lipoproteins and apolipoproteins: a prospective study. Metabolism. 33:1984;521-526.
11. Taskinen M.R., Kuusi T., Yki-Jarvinen H., Nikkila E.A. Short-term effects of prednisone on serum lipids and high density lipoprotein subfractions in normolipidemic healthy men. J Clin Endocrinol Metab. 67:1988;291-299.
12. Ettinger W.H. Jr., Hazzard W.R. Prednisone increases very low density lipoprotein and high density lipoprotein in healthy men. Metabolism. 37:1988;1055-1058.
13. Havel R.J., Eder H.A., Bragdon J.H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 34:1955;1345-1353.
14. Basu S.K., Goldstein J.L., Anderson R.G.W., Brown M.S. Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts. Proc Nat Acad Sci USA. 73:1976;3178-3182.
15. Fraenkel-Conrat H. Methods for investigating the essential groups for enzyme activity. Methods Enzymol. 4:1957;247.
16. 2 cells, macrophages and smooth muscle cells. Biochim Biophys Acta. 1126:1992;291-297.
17. Halperin G, Stein O, Stein Y. Synthesis of ether analogues of lipoprotein lipids and their biological applications. In: Colowick SP, Kaplan NO, editors, Methods in Enzymology, vol. 129: Plasma Lipoproteins. New York: Academic Press, 1986; 816-848.
18. Folch J., Lees M., Sloane-Stanley G.H. A simple method for the isolation and purification of total lipids from animal tissue. J Biol Chem. 226:1957;497-509.
19. Contreras J.A., Castro M., Bocos C., Herera E., Lasuncion M.A. Combination of an enzymatic method and HPLC for the quantitation of cholesterol in cultured cells. J Lipid Res. 33:1992;931-936.
20. Friedman G., Gallily R., Chajek-Shaul T., Stein O., Shiloni E., Etienne J., Stein Y. Lipoprotein lipase in heart cell cultures is suppressed by bacterial lipopolysaccharide: an effect mediated by production of tumor necrosis factor. Biochim Biophys Acta. 960:1988;220-228.
21. Melmed R.N., Friedman G., Chajek-Shaul T., Stein O., Stein Y. Lipoprotein lipase activity in cultured macrophage cell line J7742 and its increase in variants deficient in adenylate cyclase and cAMP-dependent protein kinase. Biochim Biophys Acta. 762:1983;58-66.
22. Cheng W., Kvilekval K.V., Abumrad N.A. Dexamethasone enhances accumulation of cholesteryl esters by human macrophages. Am J Physiol. 269:1995;E642-E648.
23. Brody R.I., Black V.H. Acyl-coenzyme A: Cholesterol acyltransferase and cholesterol ester hydrolase in the outer and inner cortices of the guinea pig adrenal: Effects of adrenocorticotropin and dexamethasone. Endocrinology. 122:1988;1722-1731.
24. Stein O., Dabach Y., Hollander G., Ben-Naim M., Halperin G., Breslow J.L., Stein Y. Delayed loss of cholesterol from a localized lipoprotein depot in apo-A-I deficient mice. Proc Natl Acad Sci USA. 94:1997;9820-9824.
25. Jansen H., van Tol A., Auwerx J., Skretting G., Staels B. Opposite regulation of hepatic lipase and lecithin: cholesterol acyltransferase by glucocorticoids in rats. Biochim Biophys Acta. 1128:1992;181-185.
26. Staels B., van Tol A., Chan L., Verhoeven G., Auwerx J. Variable effects of different corticosteroids on plasma lipids, apolipoproteins and hepatic apolipoprotein mRNA levels in rats. Arterioscler Thromb. 11:1991;760-769.
27. Taylor A.H., Raymond J., Romney J., Chan J., Lapless D.E., Wanke I.E., Wong N.C.N. Glucocorticoid increases rat apolipoprotein A-I promoter activity. J Lipid Res. 37:1996;2232-2243.
28. Petrichenko I.E., Daret D., Kolpakova G.V., Shakhov Y.A., Larrue J. Glucocorticoids stimulate cholesteryl ester formation in human smooth muscle cells. Arterioscler Thromb Vasc Biol. 17:1997;1143-1151.
29. Berard A.M., Foger B., Remaley A., Shamburek R., Vaisman B.L., Talley G., Paigen B., Hoyt R.F. Jr., Marcovina S., Brewer H.B. Jr., Santamarina-Fojo S. High plasma HDL concentrations associated with enhanced atherosclerosis in transgenic mice overexpressing lecithin-cholesteryl acyltransferase. Nature Med. 3:1997;744-749.
30. Nashel D.J. Is atherosclerosis a complication of long-term corticosteroid treatment? Am J Med. 80:1986;925-929.
31. Wallberg-Jonsson S., Ohman M.L., Rantapaa Dahlqvist S. Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in northern Sweden. J Rheumatol. 24:1997;445-451.
32. Raynauld J.-P. Cardiovascular mortality in rheumatoid arthritis: How harmful are corticosteroids? J Rheumatol. 24:1997;415-416.